7 Biologics for Asthma: What to Know About Breathing Easier With Xolair, Nucala, and More
Biologics for asthma may be considered for people with moderate to severe symptoms. Examples of asthma biologics include Xolair, Dupixent, and Nucala.
Cinqair
Used for Asthma
Used for Asthma
Cinqair (reslizumab) is an intravenous (IV) infusion given by a healthcare provider to treat severe asthma in adults when other medications aren't working well enough. It's not meant for use during asthma attacks.
What is Cinqair (reslizumab)?
What is Cinqair (reslizumab) used for?
- Severe asthma
How Cinqair (reslizumab) works
Cinqair (reslizumab) is a monoclonal antibody. It lowers the number of eosinophils (a type of white blood cell) and other cells responsible for inflammation. By lowering the amount of these cells, the medication prevents inflammation and makes it easier for you to breathe.
Drug facts
| Common Brands | Cinqair |
|---|---|
| Drug Class | Monoclonal antibody |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Prescription only |
Side effects of Cinqair (reslizumab)
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Common Side Effects
- Mouth and throat pain (3%)
- Muscle pain (2%)
Cinqair (reslizumab) serious side effects
Contact your healthcare provider immediately if you experience any of the following.
- Allergic reactions from the infusion
The following Cinqair (reslizumab) side effects have also been reported
Side effects that you should report to your care team as soon as possible:
- Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Pros and cons of Cinqair (reslizumab)
Pros
- Only has to be given once a month
- Prevents worsening of asthma and can lower the number of asthma attacks
- Good option when other asthma medications aren't working well enough
- Not too many side effects
Cons
- Has to be given in a healthcare facility; can't be injected at home
- Only works for people with asthma caused by eosinophils
- Can't be used in children
- Can cause a severe allergic reaction
Pharmacist tips for Cinqair (reslizumab)
- Cinqair (reslizumab) is usually given once every 4 weeks. It's recommended to keep track of your infusion appointments so you don't miss a dose.
- Don't stop taking any of your other asthma medications unless directed by your provider. Cinqair (reslizumab) is an add-on medication, meaning it's not meant to replace your current asthma medications.
- Let your provider know if you have any unexplained muscle aches. This could be caused by the medication.
- Before starting this medication, talk to your provider about family planning. It's not known if Cinqair (reslizumab) can harm your unborn baby.
Risks and warnings for Cinqair (reslizumab)
Cinqair (reslizumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Life-threatening allergic reaction
While rare, Cinqair (reslizumab) can cause a severe, life-threatening allergic reaction. During clinical trials, symptoms of allergic reactions were seen during the infusion or within 20 minutes after the infusion was completed. Your care team will monitor you for this and will treat you appropriately if you have this type of reaction. Seek medical help right away if you experience breathing problems, flushing, itching, swelling, or a fast heartbeat after your infusion. These could be signs of an allergic reaction.
Sudden breathing problems (asthma attacks)
Cinqair (reslizumab) isn't meant to treat sudden breathing problems or asthma attacks. Let your provider know if your asthma worsens or doesn't improve after starting Cinqair (reslizumab).
Cancerous tissue growth
In clinical trials, people taking Cinqair (reslizumab) had a higher chance of developing cancerous tissue growth. There were many different types of cancerous tissue growth, and it was usually caught in the first 6 months of using Cinqair (reslizumab).
Using corticosteroids
Cinqair (reslizumab) is not meant to replace any of your current asthma medications. If you are currently using corticosteroids, like prednisone tablets, Flovent (fluticasone) inhaler, or Qvar (beclomethasone) inhaler, don't stop taking them unless your provider tells you to. Stopping these medications too quickly can lead to unpleasant withdrawal symptoms.
Parasitic infections
- Risk factors: Helminth infections
Cinqair (reslizumab) can change the way your body fights off infections. If you happen to have a parasitic infection, your provider might treat the infection first before starting this medication. If you get an infection while taking Cinqair (reslizumab), your provider might pause the medication until your infection gets better.
Cinqair (reslizumab) dosage
Typical dosage for Cinqair (reslizumab)
Cinqair (reslizumab) is an intravenous (IV) infusion that must be administered by a healthcare provider. The dose is based on your weight and is usually given once every 4 weeks.
What are alternatives to Cinqair (reslizumab)?
There are a number of medications that your doctor can prescribe in place of Cinqair (reslizumab). Compare a few possible alternatives below.
News about Cinqair (reslizumab)
Cinqair (reslizumab) images
